FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297903490> ?p ?o ?g. }

• W4297903490 abstract "A cystic fibrosis (CF) transmembrane conductor regulator (CFTR) gene modulating triple therapy combining elexacaftor-tezacaftor-ivacaftor (Trikafta) has been recently discovered. Its approval by the Food and Drug Administration (FDA) in 2019 has expanded the target therapy group to individuals aged twelve and up with at least one Phe508del (phenylalanine 508 deletion) mutation in the CFTR gene. This systematic review aims to assess this combination therapy's safety and efficacy. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, an in-depth search was performed. The search was done by utilizing databases such as PubMed Central (PMC), Google Scholar, and Science Direct for articles related to this topic. Studies published in the last five years in the English language were chosen preliminarily. Further eligibility criteria and quality assessment tools were employed to assess the risk of bias and finalize ten articles to be used in this review. The chosen articles constituted four randomized control trials (RCTs), four systematic reviews, and two narrative reviews. The last date for data collection was April 24, 2022. Based on the findings of this review, we concluded that by combining three CFTR modulators, this therapy had outperformed all the currently available medications in terms of improving pulmonary function, reducing exacerbations, and enhancing the quality of life of CF patients. In clinical trials, headache and rash were the most common side effects, and laboratory testing to assess liver function is suggested. Long-term safety and effectiveness must be confirmed by the continued review of real-life patient data. Studies done on triple therapy thus far have been promising. Unfortunately, a small proportion of the CF population remains ineligible for any form of CFTR modulator therapy owing to their type of genetic mutation, and this provides ground for further research in this field." @default.
• W4297903490 created "2022-10-01" @default.
• W4297903490 creator A5000269203 @default.
• W4297903490 creator A5002872904 @default.
• W4297903490 creator A5009223160 @default.
• W4297903490 creator A5013799037 @default.
• W4297903490 creator A5014015399 @default.
• W4297903490 creator A5015592109 @default.
• W4297903490 creator A5029504987 @default.
• W4297903490 creator A5033277073 @default.
• W4297903490 creator A5043816650 @default.
• W4297903490 creator A5056854497 @default.
• W4297903490 creator A5066174592 @default.
• W4297903490 creator A5066190248 @default.
• W4297903490 creator A5066803607 @default.
• W4297903490 date "2022-09-20" @default.
• W4297903490 modified "2023-10-05" @default.
• W4297903490 title "Newly Discovered Cutting-Edge Triple Combination Cystic Fibrosis Therapy: A Systematic Review" @default.
• W4297903490 cites W1547235908 @default.
• W4297903490 cites W1589654967 @default.
• W4297903490 cites W2798259805 @default.
• W4297903490 cites W2884271132 @default.
• W4297903490 cites W2952212183 @default.
• W4297903490 cites W2962938491 @default.
• W4297903490 cites W2982296199 @default.
• W4297903490 cites W2985405196 @default.
• W4297903490 cites W2986760901 @default.
• W4297903490 cites W2996441745 @default.
• W4297903490 cites W3001773474 @default.
• W4297903490 cites W3010908897 @default.
• W4297903490 cites W3015162743 @default.
• W4297903490 cites W3049341660 @default.
• W4297903490 cites W3117110929 @default.
• W4297903490 cites W3137031156 @default.
• W4297903490 cites W3144543375 @default.
• W4297903490 cites W3146142859 @default.
• W4297903490 cites W3159419208 @default.
• W4297903490 cites W3166702694 @default.
• W4297903490 cites W3182318848 @default.
• W4297903490 cites W3194027733 @default.
• W4297903490 cites W3200448875 @default.
• W4297903490 cites W4200064865 @default.
• W4297903490 cites W4206217612 @default.
• W4297903490 cites W4206965127 @default.
• W4297903490 cites W4214721068 @default.
• W4297903490 cites W4225996536 @default.
• W4297903490 doi "https://doi.org/10.7759/cureus.29359" @default.
• W4297903490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36284811" @default.
• W4297903490 hasPublicationYear "2022" @default.
• W4297903490 type Work @default.
• W4297903490 citedByCount "3" @default.
• W4297903490 countsByYear W42979034902023 @default.
• W4297903490 crossrefType "journal-article" @default.
• W4297903490 hasAuthorship W4297903490A5000269203 @default.
• W4297903490 hasAuthorship W4297903490A5002872904 @default.
• W4297903490 hasAuthorship W4297903490A5009223160 @default.
• W4297903490 hasAuthorship W4297903490A5013799037 @default.
• W4297903490 hasAuthorship W4297903490A5014015399 @default.
• W4297903490 hasAuthorship W4297903490A5015592109 @default.
• W4297903490 hasAuthorship W4297903490A5029504987 @default.
• W4297903490 hasAuthorship W4297903490A5033277073 @default.
• W4297903490 hasAuthorship W4297903490A5043816650 @default.
• W4297903490 hasAuthorship W4297903490A5056854497 @default.
• W4297903490 hasAuthorship W4297903490A5066174592 @default.
• W4297903490 hasAuthorship W4297903490A5066190248 @default.
• W4297903490 hasAuthorship W4297903490A5066803607 @default.
• W4297903490 hasBestOaLocation W42979034901 @default.
• W4297903490 hasConcept C126322002 @default.
• W4297903490 hasConcept C168563851 @default.
• W4297903490 hasConcept C17744445 @default.
• W4297903490 hasConcept C177713679 @default.
• W4297903490 hasConcept C189708586 @default.
• W4297903490 hasConcept C19527891 @default.
• W4297903490 hasConcept C199539241 @default.
• W4297903490 hasConcept C2776502428 @default.
• W4297903490 hasConcept C2776938444 @default.
• W4297903490 hasConcept C2778428886 @default.
• W4297903490 hasConcept C2779473830 @default.
• W4297903490 hasConcept C535046627 @default.
• W4297903490 hasConcept C71924100 @default.
• W4297903490 hasConceptScore W4297903490C126322002 @default.
• W4297903490 hasConceptScore W4297903490C168563851 @default.
• W4297903490 hasConceptScore W4297903490C17744445 @default.
• W4297903490 hasConceptScore W4297903490C177713679 @default.
• W4297903490 hasConceptScore W4297903490C189708586 @default.
• W4297903490 hasConceptScore W4297903490C19527891 @default.
• W4297903490 hasConceptScore W4297903490C199539241 @default.
• W4297903490 hasConceptScore W4297903490C2776502428 @default.
• W4297903490 hasConceptScore W4297903490C2776938444 @default.
• W4297903490 hasConceptScore W4297903490C2778428886 @default.
• W4297903490 hasConceptScore W4297903490C2779473830 @default.
• W4297903490 hasConceptScore W4297903490C535046627 @default.
• W4297903490 hasConceptScore W4297903490C71924100 @default.
• W4297903490 hasLocation W42979034901 @default.
• W4297903490 hasLocation W42979034902 @default.
• W4297903490 hasLocation W42979034903 @default.
• W4297903490 hasOpenAccess W4297903490 @default.
• W4297903490 hasPrimaryLocation W42979034901 @default.
• W4297903490 hasRelatedWork W2036338268 @default.
• W4297903490 hasRelatedWork W2066421181 @default.

• next